Child Categories
Food & Drug Law
-
Ten Years Post-GAO Assessment, FDA Remains Uninformed of Potentially Harmful GRAS Substances in Foods
January 6, 2026
Cameron Faustman, Daniel Aaron, Nicole Negowetti & Emily Broad Leib, Ten Years Post-GAO Assessment, FDA Remains Uninformed of Potentially Harmful GRAS Substances in Foods, 61…
-
A Call to Action: The New Academy of Food Law & Policy
January 6, 2026
Emily M. Broad Leib & Susan A. Schneider, A Call to Action: The New Academy of Food Law & Policy, 13 J. Food L. &…
-
Food Law & Policy: An Essential Part of Today’s Legal Academy
January 6, 2026
Emily M. Broad Leib & Baylen J. Linnekin, Food Law & Policy: An Essential Part of Today’s Legal Academy, 13 J. Food L. & Pol’y…
-
The Future of Food Law & Policy: The Responsibility of Lawyers in the Academy and Beyond
January 6, 2026
Baylen J. Linnekin, Susan A. Schneider, Emily Broad Leib, Margaret Sova McCabe, Laurie Ristino & Michael Roberts, The Future of Food Law & Policy: The…
-
Laurie J. Beyranevand & Emily M. Broad Leib, Making the Case for a National Food Strategy in the United States, 72 Food & Drug L.J.
-
Fresh Look At Organics Bans And Waste Recycling Laws
January 6, 2026
Emily Broad Leib et al., Fresh Look At Organics Bans And Waste Recycling Laws, 57 BioCycle 16 (2016).
-
Food and the Law
January 6, 2026
Baylen J. Linnekin & Emily M. Broad Leib, Food and the Law, in Routledge International Handbook of Food Studies 238 (Ken Albala ed., 2013).
-
Pediatric Drug and Other Shortages in the Age of Supply Chain Disruption
December 29, 2025
Carmel Shachar, Philip A. Gruppuso & Eli Y. Adashi, Pediatric Drug and Other Shortages in the Age of Supply Chain Disruption, 329 JAMA 2127 (2023).
-
Assessing—and Extending—California’s Insulin Manufacturing Initiative
December 25, 2025
Jacob S. Sherkow, Eli Y. Adashi & I. Glenn Cohen, Assessing—and Extending—California’s Insulin Manufacturing Initiative, JAMA (2023).
-
Pressing Regulatory Challenges for Psychedelic Medicine
December 15, 2025
Amy L. McGuire, Holly Fernandez Lynch, Lewis A. Grossman et al., Pressing Regulatory Challenges for Psychedelic Medicine, 380 Science 347 (2023).
-
The oversight of autonomous artificial intelligence: lessons from nurse practitioners as physician extenders
December 10, 2025
Walker Morrell, Carmel Shachar & Anthony P. Weiss, The oversight of autonomous artificial intelligence: lessons from nurse practitioners as physician extenders, 9 J. L. &…
-
Robert Böhm, Cornelia Betsch, Yana Litovsky et al., Crowdsourcing interventions to promote uptake of COVID-19 booster vaccines, 53 eClinicalMedicine (2022).
-
Mutual Pharmaceutical Co. v. Bartlett and Its Implications
December 2, 2025
Brian Wolfman & Anne King, Mutual Pharmaceutical Co. v. Bartlett and Its Implications, 82 U.S.L.W., no. 17, at 1 (Nov. 5, 2013).
-
The US FDA’s New Rule for Regulating Laboratory-Developed Tests
November 27, 2025
Daniel G. Aaron, Eli Y. Adashi & I. Glenn Cohen, The US FDA’s New Rule for Regulating Laboratory-Developed Tests, 5 JAMA Health F. (2024).
-
Reconsideration of the Lifetime Ban on Blood Donation by Men Who Have Sex With Men
November 24, 2025
I. Glenn Cohen, Jeremy Feigenbaum & Eli Y. Adashi, Reconsideration of the Lifetime Ban on Blood Donation by Men Who Have Sex With Men, 312…
-
Plant-Based By Default
November 19, 2025
Lucia A. Reisch & Cass R. Sunstein, Plant-Based By Default, 4 One Earth 1205 (2021).
-
Lessons from COVID-19 for behavioural and communication interventions to enhance vaccine uptake
November 14, 2025
Stephan Lewandowsky, Philipp Schmid, Katrine Bach Habersaat et al., Lessons from COVID-19 for behavioural and communication interventions to enhance vaccine uptake, 1 Commc’ns Psych. (2023).
-
Hepatitis C Virus Treatment and Persons Who Inject Drugs
November 11, 2025
Jason Grebely, Gregory J. Dore, Robert Greenwald, Tracy Swan, Soumitri Barua & Lynn E. Taylor, Letter, Hepatitis C Virus Treatment and Persons Who Inject Drugs,…
-
When Clinical Trials Compete: Prioritising Study Recruitment
November 11, 2025
Luke Gelinas, Holly Fernandez Lynch, Barbara E. Bierer & I. Glenn Cohen, When Clinical Trials Compete: Prioritising Study Recruitment, 43 J. Med. Ethics 803 (2017).
-
The FDA is Prohibited From Going Germline
November 10, 2025
I. Glenn Cohen & Eli Y. Adashi, The FDA is Prohibited From Going Germline, 353 Science 545 (2016).
-
When Science and Politics Collide: Enhancing the FDA
November 7, 2025
Eli Y. Adashi, Rohit S. Rajan & I. Glenn Cohen, When Science and Politics Collide: Enhancing the FDA, 364 Science 628 (2019).